Adams V, Späte U, Kränkel N, Schulze PC, Linke A, Schuler G, Hambrecht R. Nuclear factor-kappa B activation in skeletal muscle of patients with chronicheart failure: correlation with the expression of inducible nitric oxidesynthase. Eur J Cardiovasc Prev Rehabil. 2003; 10:273-7.
Adler A, Messina E, Sherman B, Wang Z, Huang H, Linke A, Hintze TH. NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2 consumption by NO in old Fischer 344 rats. Am J Physiol Heart Circ Physiol. 2003; 285:H1015-22.
Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan M. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging techniques. J Magn Reson Imaging 2003; 17:3.
Boldt A, Wetzel U, Weigl J, Garbade J, Lauschke J, Hindricks G, Kottkamp H, Gummert JF, Dhein S. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J Am Coll Cardiol. 20039; 42:1785-92.
Bräunlich S, Scheinert S, Schmidt A, Biamino G, Storck M, Scheinert D. Intraarterielle Lysetherapie bei akuter Extremitätenischämie: Technische Möglichkeiten und indikatorische Grenzen. Chirurg. 2003; 74:1103-9.
Doll N, Borger MA, Fabricius A, Stephan S, Gummert J, Mohr FW, Hauss J, Kottkamp H, Hindricks G. Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high? J Thorac Cardiovasc Surg. 2003; 125:836-42.
Doll N, Fabricius AM, Gummert JF, Krakor R, Hindricks G, Kottkamp H, Mohr FW. Surgical treatment of therapy resistant atrial fibrillation. Z Kardiol. 2003; 92:712-20.
Erbs S, Baither Y, Linke A, Adams V, Shu Y, Lenk K, Gielen S, Dilz R, Schuler G, Hambrecht R. Promoter but not exon 7 polymorphism of endothelial nitric oxide synthase affects training-induced correction of endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2003; 23:1814-9.
Erbs S, Gielen S, Linke A, Möbius-Winkler S, Adams V, Baither Y, Schuler G,Hambrecht R. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am Heart J. 2003; 146:280-5.
Erbs S, Linke A, Gielen S, Fiehn E, Walther C, Yu J, Adams V, Schuler G, Hambrecht R. Exercise training in patients with severe chronic heart failure: impact on left ventricular performance and cardiac size. A retrospective analysis of the Leipzig Heart Failure Training Trial. J Cardiovasc Risk. 2003; 10:336-44
Giannuzzi P, Mezzani A, Saner H, Bjornstad H, Fioretti P, Mendes M, Cohen-Solal A, Dugmore L, Hambrecht R, Hellemans I, McGee H, Perk J, Vanhees L, Veress G. Physical activity for primary and secondary prevention. Position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. J Cardiovasc Risk. 2003; 10:319-27.
Giannuzzi P, Saner H, Bjornstad H, Fioretti P, Mendes M, Cohen-Solal A, Dugmore L, Hambrecht R, Hellemans I, McGee H, Perk J, Vanhees L, Veress G; Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Secondary prevention through cardiac rehabilitation: position paper of theWorking Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Eur Heart J. 2003; 24:1273-8.
Gielen S, Adams V, Möbius-Winkler S, Linke A, Erbs S, Yu J, Kempf W, Schubert A,Schuler G, Hambrecht R. Anti-inflammatory effects of exercise training in the skeletal muscle of patientswith chronic heart failure. J Am Coll Cardiol. 2003; 42:861-8.
Gielen S, Erbs S, Linke A, Möbius-Winkler S, Schuler G, Hambrecht R. Home-based versus hospital-based exercise programs in patients with coronary artery disease: effects on coronary vasomotion. Am Heart J. 2003; 145:E3.
Gohlke H, Kubler W, Mathes P, Meinertz T, Schuler G, Gysan DB, Sauer G;Deutschen Gesellschaft für Kardiologie--Herz-und Kreislaufforschung Bearbeitet im Auftrag des Vorstandes durch die Projekgrupe Prävention. Policy paper on primary prevention of cardiovascular diseases. Current draft of3/25/2003 issued by the Executive Committee of the German Society of Cardiology, Heart and Circulation Research. Edited by the Prevention Project Group on behalf of the Executive Committee Z Kardiol. 2003; 92:522-3.
Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, Baither Y, Gielen S,Thiele H, Gummert JF, Mohr FW, Schuler G. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation. 2003; 107:3152-8.
Hambrecht R. Drug therapy and adjuvant therapy in heart failure. Exercise training—more effective than digitalis? MMW Fortschr Med. 2003; 145:30-3.
Haude M, Konorza TF, Kalnins U, Erglis A, Saunamaki K, Glogar HD, Grube E, Gil R, Serra A, Richardt HG, Sick P, Erbel R. Heparin-COAted STents in small coronary arteries Trial Investigators. Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients. Circulation. 2003; 107:1265-70.
Heinke F, Hennig B, Sinnreich B, Kottkamp H, Schneider P, Hausler HJ. Idiopathic left ventricular tachycardia in childhood: typical clinical finding and different therapeutic options. Klin Padiatr. 2003;215:49-52.
Kazakov DV, Schmid M, Adams V, Cathomas G, Muller B, Burg G, Kempf W. HHV-8 DNA sequences in the peripheral blood and skin lesions of an HIV-negative patient with multiple eruptive dermatofibromas: implications for the detection of HHV-8 as a diagnostic marker for Kaposi's sarcoma. Dermatology. 2003; 206:217-21.
Klemm T, Mittrach-Schorin S, Neumann S, Gerike T, Krankenberg H, Schuler G, Paschke R. No association between the angiotensin-converting-enzyme gene insertion /deletion polymorphism and the occurrence of macroangiopathy in patients with diabetes mellitus type 2. Horm Metab Res. 2003; 35:43-7.
Kottkamp H, Hindricks G. Right ventricular tachycardia-arrhythmogenic right ventricular cardiomyopathy or idiopathic? Eur Heart J. 2003; 24:787-8.
Kottkamp H, Wetzel U, Schirdewahn P, Dorszewski A, Gerds-Li JH, Carbucicchio C, Kobza R, Hindricks G. Catheter ablation of ventricular tachycardia in remote myocardial infarction: substrate description guiding placement of individual linear lesions targeting noninducibility. J Cardiovasc Electrophysiol. 2003; 14:675-81.
Kränkel N, Adams V, Gielen S, Linke A, Erbs S, Schuler G, Hambrecht R. Differential gene expression in skeletal muscle after induction of heartfailure: impact of cytokines on protein phosphatase 2A expression. Mol Genet Metab. 2003; 80:262-71.
Linke A, Recchia F, Zhang X, Hintze TH. Acute and chronic endothelial dysfunction: implications for the development of heart failure. Heart Fail Rev. 2003; 8:87-97.
Linke A, Zhao G, Recchia FA, Williams J, Xu X, Hintze TH. Shift in metabolic substrate uptake by the heart during development of alloxan-induced diabetes. Am J Physiol Heart Circ Physiol. 2003; 285:H1007-14.
Niebauer J, Maxwell AJ, Lin PS, Wang D, Tsao PS, Cooke JP. NOS inhibition accelerates atherogenesis: reversal by exercise. Am J Physiol Heart Circ Physiol. 2003; 285:H535-40.
Paetsch I, Thiele H, Schnackenburg B, Bornstedt, A, Muller-York, A, Schwab, J, Fleck, E, Nagel, E. Improved functional cardiac MR imaging using the intravascular contrast agent Clariscan. Int J Cardiovasc Imaging 2003; 19:337-343.
Peschel T, Niebauer J. Role of pro-atherogenic adhesion molecules and inflammatory cytokines inpatients with coronary artery disease and diabetes mellitus type 2. Cytometry. 2003; 53B:78-85.
Peschel T, Schonauer M, Thiele H, Anker S, Schuler G, Niebauer J. Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur J Heart Fail. 2003; 5:609-14.
Rotzsch C, Dähnert I, Kostelka M, Geerdts, I, Thiele H, Bossert, T, Häusler, H J. ALCAPA. Clinical spectrum and results of surgery. Monatsschr Kinderheilkd 2003; 151:409-415.
Schulze PC, Gielen S, Adams V, Linke A, Möbius-Winkler S, Erbs S, Kratzsch J,Hambrecht R, Schuler G. Muscular levels of proinflammatory cytokines correlate with a reduced expressionof insulinlike growth factor-I in chronic heart failure. Basic Res Cardiol. 2003; 98:267-74.
Schulze PC, Kratzsch J, Linke A, Schoene N, Adams V, Gielen S, Erbs S,Moebius-Winkler S, Schuler G. Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail. 2003; 5:33-40.
Sick P, Huttl T, Niebauer J, Thiele H, Lauer B, Hambrecht R, Hentschel B,Schuler G. Influence of residual stenosis after percutaneous coronary intervention with stent implantation on development of restenosis and stent thrombosis. Am J Cardiol. 2003; 91:148-53.
Sick PB, Thiele H, Brosteanu O, Hentschel B, Lauer B, Niebauer J, Hambrecht R,Schuler G. Prospective randomized comparison of early and late results of 4 different stent designs. Am Heart J. 2003; 146:134-41.
Thiele H, Lauer B, Hambrecht R, Boudriot E, Sick P, Niebauer J, Falk V, SchulerG. Short-and long-term hemodynamic effects of intra-aortic balloon support inventricular septal defect complicating acute myocardial infarction. Am J Cardiol. 2003; 92:450-4.
Thiele H, Plein S, Breeuwer M, Ridgway JP, Thorley PJ, Schuler G, Sivananthan M. Color-encoded semiautomatic analysis for multislice first-pass magnetic resonance perfusion: Comparison to 99m technetium single-photon emission computed tomography and X-ray angiography. J Am Coll Cardiol. 2003; 41:470.
Thiele H, Plein S, Ridgway JP, Breeuwer M, Higgins D, Schuler G, Sivananthan M. Effects of missing dynamic images on myocardial perfusion reserve index calculation: comparison between an every heartbeat and an alternate heartbeatacquisition. J Cardiovasc Magn Reson. 2003; 5:343-52.
Wetzel U, Hindricks G, Dorszewski A, Schirdewahn P, Gerds-Li JH, Piorkowski C,Kobza R, Tanner H, Kottkamp H. Electroanatomic mapping of the endocardium. Implication for catheter ablation ofventricular tachycardia. Herz. 2003; 28:583-90.
Zhao G, Linke A, Xu X, Ochoa M, Belloni F, Belardinelli L, Hintze TH. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs. J Pharmacol Exp Ther. 2003; 307:182-9.
